These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 11730945

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 3. Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis.
    Khademi M, Wallström E, Andersson M, Piehl F, Di Marco R, Olsson T.
    J Neuroimmunol; 2000 Mar 01; 103(2):202-10. PubMed ID: 10696916
    [Abstract] [Full Text] [Related]

  • 4. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
    Lombardi VR, García M, Rey L, Cacabelos R.
    J Neuroimmunol; 1999 Jun 01; 97(1-2):163-71. PubMed ID: 10408971
    [Abstract] [Full Text] [Related]

  • 5. Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization.
    Lees CJ, Apostolopoulos V, McKenzie IF.
    J Interferon Cytokine Res; 1999 Dec 01; 19(12):1373-9. PubMed ID: 10638706
    [Abstract] [Full Text] [Related]

  • 6. Interferon gamma and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment.
    Franciotta D, Zardini E, Bergamaschi R, Andreoni L, Cosi V.
    J Neurol Neurosurg Psychiatry; 2003 Jan 01; 74(1):123-6. PubMed ID: 12486283
    [Abstract] [Full Text] [Related]

  • 7. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
    Killestein J, Den Drijver BF, Van der Graaff WL, Uitdehaag BM, Polman CH, Van Lier RA.
    Mult Scler; 2001 Jun 01; 7(3):145-50. PubMed ID: 11475436
    [Abstract] [Full Text] [Related]

  • 8. Spontaneous cytokine production and its effect on induced production.
    Walker D, Jason J, Wallace K, Slaughter J, Whatley V, Han A, Nwanyanwu OC, Kazembe PN, Dobbie H, Archibald L, Jarvis WR.
    Clin Diagn Lab Immunol; 2002 Sep 01; 9(5):1049-56. PubMed ID: 12204958
    [Abstract] [Full Text] [Related]

  • 9. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS.
    Zang YC, Yang D, Hong J, Tejada-Simon MV, Rivera VM, Zhang JZ.
    Neurology; 2000 Aug 08; 55(3):397-404. PubMed ID: 10932275
    [Abstract] [Full Text] [Related]

  • 10. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
    Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR.
    J Immunol; 2003 Dec 01; 171(11):6267-74. PubMed ID: 14634144
    [Abstract] [Full Text] [Related]

  • 11. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.
    J Rheumatol; 2000 May 01; 27(5):1128-35. PubMed ID: 10813277
    [Abstract] [Full Text] [Related]

  • 12. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF, Li Z, John S, Yu X, Wu CY, Ragheb JA.
    J Immunol; 2002 Sep 01; 169(5):2736-46. PubMed ID: 12193748
    [Abstract] [Full Text] [Related]

  • 13. Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.
    Sweeney ME, Slusser JG, Lynch SG, Benedict SH, Garcia SL, Rues L, LeVine SM.
    Int Immunopharmacol; 2011 Nov 01; 11(11):1796-801. PubMed ID: 21807124
    [Abstract] [Full Text] [Related]

  • 14. Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.
    Killestein J, Eikelenboom MJ, Izeboud T, Kalkers NF, Adèr HJ, Barkhof F, Van Lier RA, Uitdehaag BM, Polman CH.
    J Neuroimmunol; 2003 Sep 01; 142(1-2):141-8. PubMed ID: 14512173
    [Abstract] [Full Text] [Related]

  • 15. Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4.
    Furlan R, Bergami A, Lang R, Brambilla E, Franciotta D, Martinelli V, Comi G, Panina P, Martino G.
    J Neuroimmunol; 2000 Nov 01; 111(1-2):86-92. PubMed ID: 11063825
    [Abstract] [Full Text] [Related]

  • 16. Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.
    Nielsen CH, Börnsen L, Sellebjerg F, Brimnes MK.
    PLoS One; 2016 Nov 01; 11(1):e0146971. PubMed ID: 26756931
    [Abstract] [Full Text] [Related]

  • 17. ELISpot and ELISA analysis of spontaneous, mitogen-induced and antigen-specific cytokine production in cynomolgus and rhesus macaques.
    Mäkitalo B, Andersson M, Areström I, Karlén K, Villinger F, Ansari A, Paulie S, Thorstensson R, Ahlborg N.
    J Immunol Methods; 2002 Dec 01; 270(1):85-97. PubMed ID: 12379341
    [Abstract] [Full Text] [Related]

  • 18. Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression.
    Moldovan IR, Rudick RA, Cotleur AC, Born SE, Lee JC, Karafa MT, Pelfrey CM.
    J Neuroimmunol; 2003 Aug 01; 141(1-2):132-40. PubMed ID: 12965264
    [Abstract] [Full Text] [Related]

  • 19. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.
    Kivisäkk P, Healy BC, Viglietta V, Quintana FJ, Hootstein MA, Weiner HL, Khoury SJ.
    Neurology; 2009 Jun 02; 72(22):1922-30. PubMed ID: 19487650
    [Abstract] [Full Text] [Related]

  • 20. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
    Windhagen A, Anderson DE, Carrizosa A, Balashov K, Weiner HL, Hafler DA.
    J Neuroimmunol; 1998 Nov 02; 91(1-2):1-9. PubMed ID: 9846813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.